La Roche-Posay Effaclar Duo+ SPF30 Acne Treatment Cream for Oily and Acne Prone Skin 40ml
US$26.01
La Roche Posay Effaclar Duo(+) SPF30 protects against UV rays and environmental aggressors that can aggravate skin imperfections, fighting breakouts and minimizing the appearance of marks and blemishes. All the benefits of SPF30 protection with the comfort of a daily moisturizer. Powerful anti-imperfection, anti-mark skincare that unclogs pores and prevents breakouts, thanks to Niacinamide, LHA and Procerad.
Anti-UV Antioxidant XL Protect Technology protects skin with long UVA/UVB filters and carnosine.
Your order qualifies for free shipping!
3 in stock
EAN: 3337875549493
SKU:
LRP022
Categories: Acne Scars, Brand, Care Type, Day, Face care, Gel Cream, La Roche-Posay, Large Pores, Light, Men, Moisturizer, Niacinamide, Oil Control, Oily Skin, Skin Care, Skin Care, Women
Tag: Special Sale
Description
Description
Effaclar Duo+ SPF30 Acne Treatment Cream for Oily and Acne Prone Skin 40ml
Key Benefits:
• Imperfection-prone skin, marks.
• Exposed to daily UV, imperfections worsen and could lead to hyperpigmentation (red or brown marks).
• All the benefits of an spf 30 sunscreen with the sensoriality of a daily care in a fresh gel-cream texture.
• Tested in environment with pollution peaks.
• Fresh gel-cream, 24hr hydratation.
Key Ingredients:
NIACINAMIDE
Active ingredient for intensive soothing. Decreases redness.
PROCERAD
Helps protect against the appearance of red or brown marks. Prevents post-acne marks.
AQUA POSAE FILIFORMIS
Helps durably restore skin’s balance
MANNOSE
Stimulates the skin regeneration
How to Use:
Apply to whole face morning and/or evening after cleansing skin with Effaclar Purifying Foaming Gel. Avoid eyes contour.
Visible Results:
– Minimizes the appearance of marks
– Protects skin from sun
– Moisturizes
Reviews (0)
Be the first to review “La Roche-Posay Effaclar Duo+ SPF30 Acne Treatment Cream for Oily and Acne Prone Skin 40ml” Cancel reply
You must be logged in to post a review.
Reviews
There are no reviews yet.